社会决定因素与转移性长骨疾病急性病理性骨折的临床表现有关

IF 3.5 2区 医学 Q2 Medicine
Tom M. de Groot , Lotte R. van der Linden , Angad D.S. Bedi , Andreea A. Lucaciu , Caleb C. Jang , Olivier Q. Groot , Job N. Doornberg , Paul C. Jutte , Santiago A. Lozano-Calderon , J.H. Schwab
{"title":"社会决定因素与转移性长骨疾病急性病理性骨折的临床表现有关","authors":"Tom M. de Groot ,&nbsp;Lotte R. van der Linden ,&nbsp;Angad D.S. Bedi ,&nbsp;Andreea A. Lucaciu ,&nbsp;Caleb C. Jang ,&nbsp;Olivier Q. Groot ,&nbsp;Job N. Doornberg ,&nbsp;Paul C. Jutte ,&nbsp;Santiago A. Lozano-Calderon ,&nbsp;J.H. Schwab","doi":"10.1016/j.jbo.2025.100707","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Social Determinants of Health (SDOH) are non-medical factors that influence health, which have gained recognition across medical disciplines. Their impact on survival and disease presentation of patients with metastatic bone disease (MBD) remains unexplored.</div></div><div><h3>Methods</h3><div>This retrospective observational study included 712 undergoing surgery for symptomatic long-bone metastases patients between 2013 and 2022. SDOH were evaluated using Cox Proportional hazards regression for post-operative survival. A multivariate logistic regression analysis was performed to identify associated factors for clinical presentation with a completed pathologic fracture.</div></div><div><h3>Results</h3><div>The median overall survival was 264 days (IQR 74–772). Clinical presentation with a pathologic fracture as the initial symptom of metastatic bone disease (MBD) was observed in 15 % of patients (106/712).</div><div>SDOH factors played a significant role in clinical presentation. Patients with secondary insurance coverage were substantially less likely to present with a pathologic fracture (OR 0.26, 95 % CI 0.14–0.49; p &lt; 0.01). In a sub-analysis of the most common tumors (breast, renal, and lung cancer patients; n = 353), attending college was associated with a significantly lower likelihood of presenting with a pathologic fracture as the initial symptom of metastatic bone disease (OR 0.54, 95 % CI 0.30–0.95; p = 0.03)</div></div><div><h3>Conclusion</h3><div>This study suggests that unfavorable SDOH factors are associated with decreased post-operative survival and a higher likelihood of initial clinical presentation with a completed pathological fracture. Incorporating social determinants into comprehensive care strategies for individuals with MBD may guide targeted interventions and optimize patient management to improve outcomes.</div></div>","PeriodicalId":48806,"journal":{"name":"Journal of Bone Oncology","volume":"54 ","pages":"Article 100707"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Social determinants are associated with clinical presentation of acute pathological fracture in metastatic long-bone disease\",\"authors\":\"Tom M. de Groot ,&nbsp;Lotte R. van der Linden ,&nbsp;Angad D.S. Bedi ,&nbsp;Andreea A. Lucaciu ,&nbsp;Caleb C. Jang ,&nbsp;Olivier Q. Groot ,&nbsp;Job N. Doornberg ,&nbsp;Paul C. Jutte ,&nbsp;Santiago A. Lozano-Calderon ,&nbsp;J.H. Schwab\",\"doi\":\"10.1016/j.jbo.2025.100707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Social Determinants of Health (SDOH) are non-medical factors that influence health, which have gained recognition across medical disciplines. Their impact on survival and disease presentation of patients with metastatic bone disease (MBD) remains unexplored.</div></div><div><h3>Methods</h3><div>This retrospective observational study included 712 undergoing surgery for symptomatic long-bone metastases patients between 2013 and 2022. SDOH were evaluated using Cox Proportional hazards regression for post-operative survival. A multivariate logistic regression analysis was performed to identify associated factors for clinical presentation with a completed pathologic fracture.</div></div><div><h3>Results</h3><div>The median overall survival was 264 days (IQR 74–772). Clinical presentation with a pathologic fracture as the initial symptom of metastatic bone disease (MBD) was observed in 15 % of patients (106/712).</div><div>SDOH factors played a significant role in clinical presentation. Patients with secondary insurance coverage were substantially less likely to present with a pathologic fracture (OR 0.26, 95 % CI 0.14–0.49; p &lt; 0.01). In a sub-analysis of the most common tumors (breast, renal, and lung cancer patients; n = 353), attending college was associated with a significantly lower likelihood of presenting with a pathologic fracture as the initial symptom of metastatic bone disease (OR 0.54, 95 % CI 0.30–0.95; p = 0.03)</div></div><div><h3>Conclusion</h3><div>This study suggests that unfavorable SDOH factors are associated with decreased post-operative survival and a higher likelihood of initial clinical presentation with a completed pathological fracture. Incorporating social determinants into comprehensive care strategies for individuals with MBD may guide targeted interventions and optimize patient management to improve outcomes.</div></div>\",\"PeriodicalId\":48806,\"journal\":{\"name\":\"Journal of Bone Oncology\",\"volume\":\"54 \",\"pages\":\"Article 100707\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bone Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221213742500048X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221213742500048X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

健康的社会决定因素(SDOH)是影响健康的非医学因素,已获得医学学科的认可。它们对转移性骨病(MBD)患者的生存和疾病表现的影响尚不清楚。方法回顾性观察研究纳入2013年至2022年间712例接受手术治疗的有症状的长骨转移患者。采用Cox比例风险回归对SDOH进行术后生存评估。进行多因素logistic回归分析,以确定与完全病理性骨折的临床表现相关的因素。结果中位总生存期为264天(IQR 74-772)。15%的患者(106/712)以病理性骨折为转移性骨病(MBD)的初始症状。SDOH因素在临床表现中起重要作用。二级保险覆盖的患者出现病理性骨折的可能性大大降低(OR 0.26, 95% CI 0.14-0.49;p & lt;0.01)。在最常见肿瘤(乳腺癌、肾癌和肺癌患者)的亚分析中;n = 353),上大学与以病理性骨折为转移性骨病初始症状的可能性显著降低相关(OR 0.54, 95% CI 0.30-0.95;p = 0.03)结论:SDOH不良因素与术后生存率降低有关,其首发临床表现为完全性病理性骨折的可能性较高。将社会决定因素纳入MBD患者的综合护理策略可以指导有针对性的干预措施并优化患者管理以改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Social determinants are associated with clinical presentation of acute pathological fracture in metastatic long-bone disease

Background

Social Determinants of Health (SDOH) are non-medical factors that influence health, which have gained recognition across medical disciplines. Their impact on survival and disease presentation of patients with metastatic bone disease (MBD) remains unexplored.

Methods

This retrospective observational study included 712 undergoing surgery for symptomatic long-bone metastases patients between 2013 and 2022. SDOH were evaluated using Cox Proportional hazards regression for post-operative survival. A multivariate logistic regression analysis was performed to identify associated factors for clinical presentation with a completed pathologic fracture.

Results

The median overall survival was 264 days (IQR 74–772). Clinical presentation with a pathologic fracture as the initial symptom of metastatic bone disease (MBD) was observed in 15 % of patients (106/712).
SDOH factors played a significant role in clinical presentation. Patients with secondary insurance coverage were substantially less likely to present with a pathologic fracture (OR 0.26, 95 % CI 0.14–0.49; p < 0.01). In a sub-analysis of the most common tumors (breast, renal, and lung cancer patients; n = 353), attending college was associated with a significantly lower likelihood of presenting with a pathologic fracture as the initial symptom of metastatic bone disease (OR 0.54, 95 % CI 0.30–0.95; p = 0.03)

Conclusion

This study suggests that unfavorable SDOH factors are associated with decreased post-operative survival and a higher likelihood of initial clinical presentation with a completed pathological fracture. Incorporating social determinants into comprehensive care strategies for individuals with MBD may guide targeted interventions and optimize patient management to improve outcomes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
2.90%
发文量
50
审稿时长
34 days
期刊介绍: The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer. As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject. The areas covered by the journal include: Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment) Preclinical models of metastasis Bone microenvironment in cancer (stem cell, bone cell and cancer interactions) Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics) Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management) Bone imaging (clinical and animal, skeletal interventional radiology) Bone biomarkers (clinical and translational applications) Radiotherapy and radio-isotopes Skeletal complications Bone pain (mechanisms and management) Orthopaedic cancer surgery Primary bone tumours Clinical guidelines Multidisciplinary care Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信